Gestational Trophoblastic Neoplasia

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2012 English Publisher:Elsevier BVJournal:Obstetrics and Gynecology Clinics of North America, volume 39, pages 195-212 (issn: 0889-8545,

Copyright policy )

Authors: R, Osborne; J, Dodge;

doi: 10.1016/j.ogc.2012.03.002

pmid: 22640711

Gestational Trophoblastic Neoplasia

- Summary
- Subjects
- Metrics

Abstract

Trophoblastic neoplasms are a truly fascinating set of diseases that arise from a failed gestation. A molar pregnancy is an allograft of fetal tissue typically containing only paternal chromosomes that may invade the maternal decidua following a failed gestation that may have arisen up to decades earlier. Choriocarcinoma (CCA), the most common malignant form of trophoblastic disease, represented the very first

Related Organizations

University Health Network
Canada
Princess Margaret Cancer Centre
Canada

Keywords

Antimetabolites, Antineoplastic, Hydatidiform Mole, Prognosis, Chorionic Gonadotropin, Severity of Illness Index, Gene Expression Regulation, Neoplastic, Methotrexate, Pregnancy, Uterine Neoplasms, Biomarkers, Tumor, Dactinomycin, Humans, Female, Choriocarcinoma, Gestational Trophoblastic Disease, Neoplasm Staging

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	17
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%